David A. Siegel Emergent Bio Solutions Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 575,500 shares of EBS stock, worth $4.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
575,500
Previous 575,400
0.02%
Holding current value
$4.44 Million
Previous $3.92 Million
22.45%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding EBS
# of Institutions
158Shares Held
32.6MCall Options Held
453KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$29.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$26.2 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.49MShares$19.3 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.22MShares$17.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.91MShares$14.8 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $385M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...